Genmab — Maj 2014
-
Recommended
-
Page or document not found | European Medicines Agency (EMA)
We are sorry, but the content you tried to access is unavailable at the link you used, which was either incorrect or out-of-date. To help you find what you are looking for, we have included some useful tips.
European Medicines Agency (EMA) (www.ema.europa.eu)
-
Gazyva får også thumbs up
-
Det er så vigtigt at Arzerra
får bendamustine med på label! -
Gazyvaro, hvad fanden er det for et navn.
-
Nej. de bruger det også i USA. Det er godkendt som mono-terapi, men ikke tidligere i kombi med cd20 antistof. Så vidt jeg ved er det brugt en del i kombi med rituximab off-label
-
Nej, der fik vi kun clorambucil på labelen
-
Men det kan vel trække lidt off-label i USA, at det er godkendt i kombination i Europa.
-
hvor lang tid plejer der at gå inden EU-Kommissionen tager endelig belustning ? Citat MedWath idag
: "Den positive anbefaling vil komme patienter med kronisk lymfatisk leukæmi, der ikke hidtil har modtaget behandling, til gode, såfremt EU-Kommission vælger at følge komitéens anbefaling"
anbefaler udvidet brug af ArzerraHello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind